Zerodha (Trading & Demat Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
Zerodha (Trading & Demat Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
|
Track all the latest updates and news of Aristo Bio-Tech and Lifescience IPO.
March 28, 2024 3:31:00 AM
Aristo Bio-Tech & Lifescience Ltd share price was down by ... fraud Swiggy recorded a $200 million loss ahead of potential IPO, claims report Despite job cuts globally, big consulting firms ...
Published by : Business TodayMarch 28, 2024 10:40:00 AM
Boundless Bio is bringing in $100 million from its IPO as the precision oncology company becomes the latest biotech to go public in 2024. The company has priced its 6.25 million shares at $16 ...
Published by : FierceBiotechApril 5, 2024 10:30:00 AM
Contineum Therapeutics has lowered its IPO expectations as the Johnson & Johnson-partnered biotech prepares to make the jump to the public markets this morning Friday, April 5. The San Diego-based ...
Published by : FierceBiotechApril 1, 2024 3:30:00 AM
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Hey there. Today, we learn about how scientists had a happenstance ...
Published by : STATApril 18, 2024 9:46:00 PM
Ibotta began its path as a public company on Thursday by opening at $117 per share, a big increase from its IPO price of $88, itself an increase from its proposed range of $76 to $84 per share.
Published by : TechCrunchMarch 29, 2024 3:30:00 AM
It has shown the same promise among people with general obesity. The San Diego-based biotech is close to completing a pre-IPO financing round in which it will raise between $75mn and $100mn from a ...
Published by : The Financial TimesApril 12, 2024 3:30:00 AM
The sum is more than three times the $375 million in total proceeds from biotech ... from life sciences companies to list on the exchange, including a number that had indicated IPOs plans in ...
Published by : Yahoo FinanceMarch 29, 2024 3:30:00 AM
the latest biotech IPO, and intrigue over Chinese outsourcing. Damian Garde covered biotech, was a co-writer of The Readout newsletter, and was a co-host of "The Readout LOUD" podcast.
Published by : STATApril 4, 2024 3:30:00 AM
Contineum�s offering keeps biotech IPOs on their strongest pace in three years, according to BioPharma Dive data. By this time last year, only four drug startups had gone public, raising $375 ...
Published by : Yahoo FinanceMarch 25, 2024 3:30:00 AM
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings ...
Published by : MorningstarApril 19, 2024 3:30:00 AM
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Published by : MorningstarApril 18, 2024 3:30:00 AM
1 Day ARISTO 1.36% DJIA -0.12% Russell 2K -0.99% Basic Materials/Resources -0.11% ...
Published by : Wall Street JournalThe allotment status of Aristo Bio-Tech and Lifescience Limited IPO is now available online. The public issue of Aristo Bio-Tech and Lifescience IPO was open on Jan 16, 2023 and closed for subscription on Jan 19, 2023. The equity shares of the company to be list at NSE SME
.
The IPO Shares of Aristo Bio-Tech and Lifescience Limited IPO are proposed to list on Monday, January 30, 2023 at NSE SME. The public issue of Aristo Bio-Tech and Lifescience IPO was opened on Jan 16, 2023 and closed for subscription on Jan 19, 2023. Aristo Bio-Tech and Lifescience IPO Listing Date and Information:
| Listing Date | Monday, January 30, 2023 |
| BSE Script Code | |
| NSE Symbol | ARISTO |
| Listing In | |
| ISIN | INE082101010 |
| Issue Price | ₹72 Per Equity Share |
| Face Value | ₹10 Per Equity Share |
SME : Aristo Bio-Tech and Lifescience Limited is entering in the capital market with an IPO of 1,812,800 Equity Shares of Rs 10 aggregating up to Rs 13.05 Crore. The price for the issue has been set at Rs 72 Per Equity Share.
Incorporated in 2005, Aristo Bio-Tech and Lifescience Limited is an agrochemical company. They are mainly engaged in the manufacturing, formulation, supplying, packaging, and job work services of various Pesticides.
The issue opens on Jan 16, 2023 and closes for subscription on Jan 19, 2023. The equity shares of the company to be list at NSE SME.
SME: The issue of Aristo Bio-Tech and Lifescience Limited opens on Jan 16, 2023 and closes for subscription on Jan 19, 2023. The equity shares of the company to be list at NSE SME. The price for the issue has been set at Rs 72 Per Equity Share.
The Aristo Bio-Tech and Lifescience IPO is proposed to open on January 16, 2023. The IPO application ends on January 19, 2023.
Retail investors can apply in the retail or non-institutional investor category from January 16, 2023 to January 19, 2023. The Aristo Bio-Tech and Lifescience IPO can be applied online through Net Bank (ASBA method) or the stock broker (UPI method).
The Aristo Bio-Tech and Lifescience IPO will open for subscription on January 16, 2023. The public issue will close on January 19, 2023.
Useful Articles
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|
|
RHP
